deltatrials
Terminated PHASE1 INTERVENTIONAL 2-arm NCT02893826

Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH

Multicenter, Controlled, Randomized, Safety and Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage

Sponsor: Edge Therapeutics Inc

Conditions Subarachnoid Hemorrhage, Aneurysmal
Interventions EG-1962 (nimodipine microparticles) Enteral Nimodipine
Updated 10 times since 2017 Last updated: Jul 24, 2018 Started: Sep 30, 2016 Primary completion: Dec 31, 2017 Completion: Mar 31, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Based on DMC recommendation to discontinue EG-01-1962-03

Other terminated trials from Edge Therapeutics Inc

More terminations from Edge Therapeutics Inc

Other Subarachnoid Hemorrhage, Aneurysmal trials with similar outcome

Browse all Subarachnoid Hemorrhage, Aneurysmal trials

Listed as NCT02893826, this PHASE1 trial focuses on Subarachnoid Hemorrhage, Aneurysmal and remains terminated or withdrawn. Sponsored by Edge Therapeutics Inc, it has been updated 10 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotNot Yet Recruiting~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshotRecruiting~Apr 2017 – ~Jul 2017 · 3 months · monthly snapshotRecruiting~Jul 2017 – ~May 2018 · 10 months · monthly snapshotRecruiting~May 2018 – ~Jun 2018 · 31 days · monthly snapshotTerminated~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshotTerminated~Aug 2018 – ~Jan 2021 · 29 months · monthly snapshotTerminated~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 22 months · monthly snapshotTerminated

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE1

  4. Aug 2018 — Jan 2021 [monthly]

    Terminated PHASE1

  5. Jun 2018 — Aug 2018 [monthly]

    Terminated PHASE1

▶ Show 5 earlier versions

  1. May 2018 — Jun 2018 [monthly]

    Terminated PHASE1

    Status: Recruiting → Terminated

  2. Jul 2017 — May 2018 [monthly]

    Recruiting PHASE1

  3. Apr 2017 — Jul 2017 [monthly]

    Recruiting PHASE1

  4. Feb 2017 — Apr 2017 [monthly]

    Recruiting PHASE1

    Status: Not Yet Recruiting → Recruiting

  5. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Sep 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Edge Therapeutics Inc
Data source: Edge Therapeutics Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations